bbx posts
FeedPosted Feb 26th 2009 10:00AM by Jim Cramer (RSS feed)
Filed under: Market matters, Amer Intl Group (AIG), Wells Fargo (WFC), Cramer on BloggingStocks, Financial Crisis
TheStreet.com's Jim Cramer says everything depends upon these financial programs. Maybe Sheila Bair doesn't matter at all. Maybe nothing matters. The chatter behind the scenes everywhere is, "Just let it happen, it can't be any worse than this."
I say, are you kidding me? Do you know that our whole country would simply stop if we didn't have these programs and these government promises?
Think of it like this: If you have models that show 10% unemployment and you offer credit cards, your model says don't offer them. But if the government didn't guilt-trip these companies into offering them, you couldn't get one.
Continue reading Cramer on BloggingStocks: If we 'let it happen,' the center cannot hold
Posted Feb 11th 2009 11:42AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Analyst upgrades and downgrades, Best Buy (BBY), Yamana Gold (AUY), Analyst initiations, Freep't McMoRan Copper (FCX), Anglo American (AAUKY)
Analyst upgrades:
- Deutsche Bank upgraded shares of Camden Property (NYSE: CPT) to Hold from Sell on valuation and believes the company has improved its liquidity position. Despite the upgrade, the firm lowered its target price to $21 from $25.
- Goldman added Best Buy (NYSE: BBY) to its Conviction Buy List as it is now the sole dominant retailer in consumer electronics and expects Best Buy's margins to benefit from Circuit City's demise.
- Molson Coors (NYSE: TAP) was upgraded to Overweight from Neutral at JP Morgan as it finds the valuation attractive and sees a number of long-term fundamental positive catalysts. The firm has a $47.50 target on shares.
- United Rentals (NYSE: URI) and Illinois Tool Works (NYSE: ITW) were upgraded to Buy from Neutral at UBS.
- ProLogis (NYSE: PLD) was upgraded to Buy from Neutral at Banc of America/Merrill.
Analyst downgrades:
- Oppenheimer downgraded Global Traffic Network (NASDAQ: GNET) to Perform from Outperform following the company's weaker than expected Q2 results and lowered its target price to $6.25 from $7.
- Friedman Billings downgraded BankAtlantic (NYSE: BBX) to Underperform from Market Perform to reflect the deterioration of both the company's credit and capital in Q4. The firm lowered its target price to $1 from $5.
- RBC Capital downgraded AbitibiBowater (NYSE: ABH) to Underperform from Sector Perform and lowered its target to 50 cents from $2.00 following the company's debt refinancing announcement.
- Lions Gate (NYSE: LGF) was cut to Market Weight from Overweight at Thomas Weisel.
- Ctrip.com (NASDAQ: CTRP) was downgraded at Goldman to Sell from Neutral.
- Molson Coors (NYSE: TAP) was downgraded to Neutral from Buy at Banc of America/Merrill.
Analyst initiations:
- Oppenheimer initiated Chattem (NASDAQ: CHTT) with an Outperform rating and believes the company's business model is well suited for the current uncertain consumer environment. The firm has an $80 target on the stock.
- Freeport McMoRan (NYSE: FCX) was initiated at BMO Capital with a Market Perform rating and $30 target.
- Anglo American (NASDAQ: AAUK) was assumed with a Sell rating at Societe Generale.
- Yamana Gold (NYSE: AUY) was started at UBS with a Buy rating.
Posted Aug 1st 2007 11:34AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst reports, Analyst upgrades and downgrades, Bad news, Amgen Inc (AMGN)
MOST NOTEWORTHY: TDK Corp. (TDK), Maquire Properties (MPG), BankAtlantic Bancorp (BBX), ON Semiconductor (ONNN) and Amgen (AMGN) were today's noteworthy downgrades:
- UBS downgraded TDK Corp. (NYSE: TDK) to Reduce from Neutral after the company's operating profit missed estimates.
- Deutsche Bank cut Maguire Properties (NYSE: MPG) to Sell from Hold following the company's disappointing Q2 report.
- Valuation and debt levels pushed Unterberg to downgrade ON Semiconductor (NASDAQ: ONNN) to Market Perform from Buy.
- William Blair downgraded shares of Amgen (NASDAQ: AMGN) to Market Perform from Outperform as they believe the CMS decision on ESA reimbursement guidelines is extremely restrictive regarding Aranesp use in oncology...
OTHER DOWNGRADES:
- Stanford downgraded MoSys (NASDAQ: MOSY) to Hold from Buy.
- Buckingham cut Cephalon (NASDAQ: CEPH) to Accumulate from Strong Buy.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).